While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 ...

New Alzheimer’s drugs known as anti-amyloid therapies may slow disease progression—but they also carry serious risks, ...

One of neurologist Anelyssa D’Abreu’s least favorite tasks is giving her patients a dreaded diagnosis: early-stage ...

More than seven million Americans suffer from Alzheimer’s disease, but experts are working hard to make sure fewer people suffer in the future. One local Alzheimer’s expert, Dr. Hamid Okhravi of ...

EXCLUSIVE: A once-a-day “holy grail” pill that could change the way Alzheimer’s disease is treated has reached a significant ...

Retro Biosciences is set to run a clinical trial for an aging drug designed to reverse Alzheimer's, its CEO Joe Betts-LaCroix ...

New research suggests that lithium is depleted in the brains of Alzheimer's patients and is essential for normal brain ...

Lithium can be toxic if not used properly. Further, the research is still in the early stages and it is unlikely that a ...

Neurosense Therapeutics Ltd. ( ($NRSN) ) has issued an announcement. On September 10, 2025, NeuroSense Therapeutics Ltd. announced promising ...

By analyzing blood biomarkers in more than 5,700 Hispanic and Latino adults, researchers at UC San Diego identified proteins ...

To solve a problem, we have to see it clearly. Whether it's an infection by a novel virus or memory-stealing plaques forming ...

The timing of hormone replacement therapy may make a big difference in a woman's risk of developing Alzheimer's disease.